Do magnetic resonance imaging features differ between persons with multiple sclerosis of various races and ethnicities?

African American Latin American ethnicity magnetic resonance imaging multiple sclerosis neuroimaging race

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2023
Historique:
received: 02 05 2023
accepted: 12 06 2023
medline: 14 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: epublish

Résumé

Those of African American or Latin American descent have been demonstrated to have more severe clinical presentations of multiple sclerosis (MS) than non-Latin American White people with MS. Concurrently, radiological burden of disease on magnetic resonance imaging (MRI) in African Americans with MS has also been described as being more aggressive. Here, we review MRI studies in diverse racial and ethnic groups (adult and pediatric) investigating lesion burden, inflammation, neurodegeneration, and imaging response to disease modifying therapy. We also discuss why such disparities may exist beyond biology, and how future studies may provide greater insights into underlying differences.

Identifiants

pubmed: 37448745
doi: 10.3389/fneur.2023.1215774
pmc: PMC10338060
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1215774

Subventions

Organisme : NIA NIH HHS
ID : U54 AG044170
Pays : United States

Informations de copyright

Copyright © 2023 Nathoo, Zeydan, Neyal, Chelf, Okuda and Kantarci.

Déclaration de conflit d'intérêts

DO received personal compensation for consulting and advisory services from Alexion, Biogen, Celgene/Bristol Myers Squibb, EMD Serono, Genentech, Genzyme, Janssen Pharmaceuticals, Novartis, Osmotica Pharmaceuticals, RVL Pharmaceuticals, Inc., TG Therapeutics, and research support from Biogen, Novartis, and EMD Serono/Merck. DO has issued national and international patents along with pending patents related to other developed technologies. DO received royalties for intellectual property licensed by The Board of Regents of The University of Texas System. BZ receives research funding from the NIH (U54 AG044170) and is supported by the Mayo Clinic Eugene and Marcia Applebaum Award. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Brain. 2018 Nov 1;141(11):3115-3129
pubmed: 30312381
Am J Public Health. 2011 Aug;101(8):1456-65
pubmed: 21680937
Eur Neurol. 2011;65(3):119-22
pubmed: 21325853
Biomedicines. 2020 Nov 25;8(12):
pubmed: 33255552
Mult Scler. 2023 May;29(6):691-701
pubmed: 36507671
J Neuroimaging. 2017 Sep;27(5):476-480
pubmed: 28371088
BMC Neurol. 2013 Nov 13;13:173
pubmed: 24225378
J Neurol. 2007 Sep;254(9):1212-20
pubmed: 17361339
J Neuroimaging. 2017 May;27(3):333-338
pubmed: 27634620
Neuroimage Clin. 2022;35:103101
pubmed: 35792417
J Neurol. 2009 Jul;256(7):1061-6
pubmed: 19252775
Neurology. 2014 Jun 17;82(24):2173-9
pubmed: 24850491
Neuroepidemiology. 2018;50(1-2):35-40
pubmed: 29339633
Pediatr Neurol. 2009 Jan;40(1):31-3
pubmed: 19068251
Neurol Neuroimmunol Neuroinflamm. 2019 Oct 31;7(1):
pubmed: 31672834
Neurology. 2022 May 3;98(18):e1818-e1827
pubmed: 35501161
Mult Scler Relat Disord. 2020 Oct;45:102429
pubmed: 32805478
Mult Scler Relat Disord. 2021 Aug;53:103025
pubmed: 34052742
Neurology. 2011 May 24;76(21):1824-30
pubmed: 21606454
J Neuroimaging. 2021 Jan;31(1):115-123
pubmed: 32949483
BMC Neurol. 2021 Jul 27;21(1):295
pubmed: 34311734
Mult Scler. 2009 Dec;15(12):1537-8
pubmed: 20019098
JAMA Neurol. 2021 Dec 1;78(12):1515-1524
pubmed: 34605866
Clin Neurol Neurosurg. 2011 Oct;113(8):617-22
pubmed: 21621913
Science. 2022 Jan 21;375(6578):296-301
pubmed: 35025605
BMC Neurol. 2014 Jan 29;14:21
pubmed: 24475777
Arch Neurol. 2009 Aug;66(8):967-71
pubmed: 19667217
Neurology. 2021 Aug 31;97(9):e881-e889
pubmed: 34193590
Mult Scler. 2020 Apr;26(5):561-567
pubmed: 31965878
Mult Scler. 2013 Jun;19(7):844-54
pubmed: 23045380
Nat Rev Neurol. 2022 Dec;18(12):723-734
pubmed: 36369488
Clin Ther. 2020 Jul;42(7):1292-1301
pubmed: 32593474
Mult Scler Relat Disord. 2018 Oct;25:50-56
pubmed: 30036854
Mult Scler Relat Disord. 2021 Jun;51:102903
pubmed: 33780808
Adv Ther. 2014 Oct;31(10):1072-81
pubmed: 25245812
Neurology. 2010 Feb 16;74(7):538-44
pubmed: 20089944
Mult Scler. 2013 Oct;19(11):1493-8
pubmed: 23407702
Neurology. 2017 Sep 26;89(13):1330-1337
pubmed: 28855411
Neurology. 2004 Dec 14;63(11):2039-45
pubmed: 15596747
J Clin Immunol. 1989 May;9(3):214-22
pubmed: 2788656
Neurology. 2022 Mar 1;98(9):e880-e892
pubmed: 35046135
NMR Biomed. 2023 Mar;36(3):e4846
pubmed: 36259628
Arch Intern Med. 2009 Mar 23;169(6):626-32
pubmed: 19307527
PLoS Genet. 2019 Jan 17;15(1):e1007808
pubmed: 30653506
Mult Scler J Exp Transl Clin. 2016 Jul 4;2:2055217316657117
pubmed: 28607733
J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1109-15
pubmed: 24554101
Neurology. 2008 Mar 25;70(13 Pt 2):1141-9
pubmed: 18362274
Nature. 2023 Mar;615(7952):391-393
pubmed: 36918678
Ann Neurol. 2008 Sep;64(3):255-65
pubmed: 18661561
Ethiop J Health Sci. 2021 Sep;31(5):1043-1052
pubmed: 35221622
Mult Scler Relat Disord. 2023 Mar;71:104523
pubmed: 36773543
Int J Environ Res Public Health. 2021 Aug 02;18(15):
pubmed: 34360456
Nat Rev Microbiol. 2023 Jan;21(1):51-64
pubmed: 35931816
Mult Scler J Exp Transl Clin. 2017 Jun 13;3(2):2055217317715050
pubmed: 28638628
J Neurol Neurosurg Psychiatry. 1994 Sep;57(9):1064-9
pubmed: 8089669
J Neuroinflammation. 2018 Sep 5;15(1):255
pubmed: 30185189
JCI Insight. 2017 Nov 16;2(22):
pubmed: 29202449
Neurol Clin Pract. 2015 Apr;5(2):132-142
pubmed: 26137421
Neurology. 2022 Jun 14;98(24):1015-1020
pubmed: 35470139
Arch Neurol. 2005 Nov;62(11):1681-3
pubmed: 16286540
Mult Scler Relat Disord. 2022 Jul;63:103920
pubmed: 35661567
Neurol Ther. 2020 Dec;9(2):483-493
pubmed: 32472386
Clin Neurol Neurosurg. 2013 Aug;115(8):1333-7
pubmed: 23395161
Mult Scler. 2012 Dec;18(12):1782-90
pubmed: 22492130
Neurology. 2013 May 7;80(19):1734-9
pubmed: 23650231
Arch Neurol. 2011 Apr;68(4):464-8
pubmed: 21482925
Mult Scler. 2018 May;24(6):710-720
pubmed: 28474969
PLoS One. 2012;7(8):e43061
pubmed: 22900088
JAMA Neurol. 2019 Dec 1;76(12):1474-1483
pubmed: 31403674
Pediatr Neurol. 2006 Nov;35(5):327-34
pubmed: 17074603
Mult Scler Relat Disord. 2022 Jul;63:103830
pubmed: 35490448
Mult Scler Relat Disord. 2018 Oct;25:29-36
pubmed: 30029018
Mult Scler. 2012 Sep;18(9):1269-77
pubmed: 22354739

Auteurs

Nabeela Nathoo (N)

Division of Multiple Sclerosis and Autoimmune Neurology, Department of Neurology, Mayo Clinic, Rochester, MN, United States.

Burcu Zeydan (B)

Division of Multiple Sclerosis and Autoimmune Neurology, Department of Neurology, Mayo Clinic, Rochester, MN, United States.
Department of Radiology, Mayo Clinic, Rochester, MN, United States.

Nur Neyal (N)

Division of Multiple Sclerosis and Autoimmune Neurology, Department of Neurology, Mayo Clinic, Rochester, MN, United States.
Department of Radiology, Mayo Clinic, Rochester, MN, United States.

Cynthia Chelf (C)

Mayo Clinic College of Medicine and Science, Library-Public Services, Mayo Clinic, Rochester, MN, United States.

Darin T Okuda (DT)

Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, TX, United States.

Orhun H Kantarci (OH)

Division of Multiple Sclerosis and Autoimmune Neurology, Department of Neurology, Mayo Clinic, Rochester, MN, United States.

Classifications MeSH